Marvelon (Desogestrel, Ethinylestradiol)

Marvelon, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy.

• Prevention of pregnancy: provides reliable contraceptive protection when taken daily as directed.
• Menstrual cycle regulation: helps achieve more predictable bleeding patterns and may reduce menstrual cramps.
• Acne management: can improve mild to moderate acne by reducing circulating androgen levels.

• Desogestrel and ethinylestradiol act together to suppress the mid‑cycle surge of luteinising hormone (LH) and follicle‑stimulating hormone (FSH), thereby inhibiting ovulation. The estrogen component stabilises the endometrial lining, while both agents thicken cervical mucus, creating an environment less conducive to sperm penetration and implantation.

Marvelon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild stomach upset, often improves after the first cycle.
• Headache: tension‑type or migraine‑like pain.
• Breast tenderness: swelling or soreness of the breasts.
• Weight gain: modest increase due to fluid retention.
• Mood changes: irritability or mild depressive symptoms.
• Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects

• Venous thromboembolism: blood clots in deep veins or lungs.
• Arterial thrombosis: clot formation in arteries, potentially causing stroke or heart attack.
• Hypertension: elevated blood pressure requiring monitoring.
• Liver dysfunction: abnormal liver enzymes or jaundice.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Visual disturbances: sudden vision loss or blurred vision.

Before prescribing Marvelon, clinicians should evaluate individual risk factors and counsel patients on safe use.

• Assess cardiovascular risk: review history of thrombosis, smoking, hypertension, and obesity.
• Avoid use in smokers over 35 years: increased risk of serious clotting events.
• Consider liver function: contraindicated in active liver disease or severe hepatic impairment.
• Monitor blood pressure: oral contraceptives may raise systolic and diastolic values.
• Review medication list: certain enzyme‑inducing drugs can reduce contraceptive efficacy.
• Store at ambient temperature: keep below 25 °C, in the original pack, and protect from moisture.

Marvelon can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may markedly reduce hormonal levels and contraceptive protection.
• Rifampicin: decreases ethinylestradiol concentrations, increasing risk of unintended pregnancy.
• Protease inhibitor ritonavir: can raise hormone levels, heightening the chance of thrombotic events.

Moderate Interactions (Monitor Closely)

• Broad‑spectrum antibiotics (e.g., ampicillin, tetracycline): may slightly diminish contraceptive efficacy.
• St. John’s wort: herbal inducer that can lower hormone concentrations.
• Thiazide diuretics: may exacerbate blood‑pressure‑raising effects of the estrogen component.